Related Experiment Video
Updated: Jul 11, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Iridoids from Pentas lanceolata
Jan Schripsema1, Geisa Paulino Caprini, Rob van der Heijden
1Analytical Biotechnology, Department of Biotechnology, Delft University of Technology, Julianalaan, Delft, The Netherlands. j.schripsema@tudelft.nl
Researchers isolated seven iridoid glucosides from Pentas lanceolata, including five novel compounds. One previously identified compound was revised, and the configuration of two others was clarified.
Area of Science:
- Phytochemistry
- Natural Product Chemistry
- Organic Chemistry
Background:
- Pentas lanceolata (Rubiaceae family) is a source of bioactive compounds.
- Iridoid glucosides are significant secondary metabolites in the Rubiaceae family.
Purpose of the Study:
- To isolate and identify iridoid glucosides from the aerial parts of Pentas lanceolata.
- To characterize novel iridoid glucosides and revise existing structures.
Main Methods:
- Preparative High-Performance Liquid Chromatography (HPLC) for isolation.
- Spectroscopic methods for structural elucidation and configuration determination.
Main Results:
- Seven iridoid glucosides were identified, including known compounds asperuloside and asperulosidic acid.
- Five new iridoid glucosides were isolated: tudoside (1), 13R-epi-gaertneroside (2), 13R-epi-epoxygaertneroside (3), and a mixture of E-uenfoside (4) and Z-uenfoside (5).
- Citrifolinin B (6) was identified as identical to tudoside, necessitating a revision.
- The configuration of gaertneroside and epoxygaertneroside was elucidated.
Conclusions:
- The study expands the known diversity of iridoid glucosides in Pentas lanceolata.
- Structural revisions and configuration elucidation contribute to the understanding of iridoid chemistry within the Rubiaceae family.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Red Algae
Renewal of Intestinal Stem Cells